Literature DB >> 22345381

The relationship between airflow obstruction, emphysema extent, and small airways function in COPD.

Sophie C Timmins1, Chantale Diba2, Catherine E Farrow3, Robin E Schoeffel4, Norbert Berend3, Cheryl M Salome3, Gregory G King5.   

Abstract

BACKGROUND: The severities of COPD (FEV(1) % predicted) and airflow obstruction (FEV(1)/FVC) are considered to be due to both emphysema and small airways disease. To our knowledge, this has not been previously confirmed by combined measurements of emphysema and of small airway function. We hypothesized that small airways disease and emphysema extent contribute independently to the severity of both COPD and airflow obstruction.
METHODS: Twenty-six subjects with COPD underwent measurements with forced oscillation technique (FOT) at 6 Hz and single-breath nitrogen washout. Respiratory system resistance, respiratory system reactance (Xrs), and expiratory flow limitation (EFL) index (measured as mean inspiratory Xrs − expiratory Xrs) were derived from FOT. Closing volume/vital capacity (CV/VC) was derived from the washout. Emphysema extent was measured as low attenuation areas < -910 Hounsfield units, expressed as a percentage of CT scan lung volume from multislice CT scans taken at total lung capacity.
RESULTS: Subjects were aged (mean ± SD) 69.6 ± 8.0 years. Postbronchodilator FEV(1) was 64.8 ± 19.8% predicted, and diffusing capacity of lung for carbon monoxide was 50.7 ± 15.8% predicted. Emphysema extent was 22.6% ± 15.0% CT scan volume. CV/VC was 16.9% ± 7.9%; Xrs, -3.72 ± 3.03 cm H(2)O/L/s; and EFL index, 3.88 ± 3.93 cm H(2)O/L/s. In multiple regression analyses, FEV(1)/FVC was predicted by both emphysema and CV/VC (model r(2) = 0.54, P < .0001) whereas FEV(1) % predicted was predicted by emphysema and EFL index (model r(2) = 0.38, P = .0014).
CONCLUSIONS: The severities of COPD and airflow obstruction are independently predicted by both small airways disease and emphysema extent.

Entities:  

Mesh:

Year:  2012        PMID: 22345381     DOI: 10.1378/chest.11-2169

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

1.  Computed Tomography Findings of Bronchiectasis in Different Respiratory Phases Correlate with Pulmonary Function Test Data in Adults.

Authors:  Ricardo Holderbaum do Amaral; Carlos S Nin; Vinicius V S de Souza; Giordano R T Alves; Edson Marchiori; Klaus Irion; Gustavo S P Meirelles; Bruno Hochhegger
Journal:  Lung       Date:  2017-03-28       Impact factor: 2.584

2.  Clinical Significance of Forced Oscillation Technique for Evaluation of Small Airway Disease in Interstitial Lung Diseases.

Authors:  Masashi Mikamo; Tomoyuki Fujisawa; Yoshiyuki Oyama; Masato Kono; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Hiromitsu Sumikawa; Takeshi Johkoh; Takafumi Suda
Journal:  Lung       Date:  2016-10-12       Impact factor: 2.584

3.  Correlations between small airway function, ventilation distribution, and functional exercise capacity in COPD patients.

Authors:  Agnaldo José Lopes; Thiago Thomaz Mafort
Journal:  Lung       Date:  2014-07-22       Impact factor: 2.584

4.  Cigarette smoking and airway wall thickness on CT scan in a multi-ethnic cohort: the MESA Lung Study.

Authors:  Kathleen M Donohue; Eric A Hoffman; Heather Baumhauer; Junfeng Guo; Matthew Budoff; John H M Austin; Ravi Kalhan; Steven Kawut; Russell Tracy; R Graham Barr
Journal:  Respir Med       Date:  2012-09-10       Impact factor: 3.415

Review 5.  Advanced imaging in COPD: insights into pulmonary pathophysiology.

Authors:  Stephen Milne; Gregory G King
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

6.  Comparison of four software packages for CT lung volumetry in healthy individuals.

Authors:  Stefan F Nemec; Francesco Molinari; Valerie Dufresne; Natacha Gosset; Mario Silva; Alexander A Bankier
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

7.  Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Steven M Kawut; David A Bluemke; Robert C Basner; Antoinette S Gomes; Eric Hoffman; Ravi Kalhan; João A C Lima; Chia-Ying Liu; Erin D Michos; Martin R Prince; LeRoy Rabbani; Daniel Rabinowitz; Daichi Shimbo; Steven Shea; R Graham Barr
Journal:  Circulation       Date:  2013-03-14       Impact factor: 29.690

8.  Sex-specific features of emphysema among current and former smokers with COPD.

Authors:  Megan Hardin; Marilyn Foreman; Mark T Dransfield; Nadia Hansel; MeiLan K Han; Michael H Cho; Surya P Bhatt; Joe Ramsdell; David Lynch; Jeffrey L Curtis; Edwin K Silverman; George Washko; Dawn DeMeo
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

9.  Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study.

Authors:  Jun-Jun Yeh; Yu-Chiao Wang; Fung-Chang Sung; Christine Yi-Ting Chou; Chia-Hung Kao
Journal:  Lung       Date:  2014-04-02       Impact factor: 2.584

10.  Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.

Authors:  Paola Rogliani; Maria Gabriella Matera; Francesco Facciolo; Clive Page; Mario Cazzola; Luigino Calzetta
Journal:  Br J Pharmacol       Date:  2020-01-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.